Oncotarget is a term that is it came from some scientific terms. They all are biologic processes that need to be looked into in detailed and solve the problems that may face the processes. That is what the journal tries to address, the latest research and solutions to biological defects. It involves articles that surround all molecules, biological pathways, cell purposes, cancer development and aging (neurodegeneration.) The journal also publishes things that affect the cancerous cells, brain cells, heart, lymphocytes, and microorganisms.
The aim of creating the journal was to make the research updates available to the people who were interested. People with more ideas and insights could add up to the debate then put more valuable contribution. In the process, there will be rapid development progress in the scientific discoveries which are going to be available to the people.
Oncortaget is a journal that combines various fields and specialties in orders for innovations to be realized. Different career scientists come together to create a comprehensive article that will be able to help people and improve the quality of living. The linking of various fields in biomedical science is helpful, and the journal editorial team led by Mikhail Blagosklonny gives the best final draft that is very accurate.
In the long run, there are applications due to the findings used in our day to day lives and in clinical science to cure diseases and prevent an attack from ailments too like for example cancer. Topics like preventing aging too can be discussed and recommendations made on how to reduce aging. E-cigarettes and their effects which are mostly negative are also published in Oncortarget. As a result, it will discourage the use of the cigarettes.
Oncortarget as a journal is owned and led by very qualified scientists who do not publish articles before researching. They, first of all, get the points straight so that they can then put it on paper. The journals will help researchers get more contributions to the advancement of science and solve problems. The main aim of Oncotarget is to eradicate diseases and prevent people from aging and death.
About Oncotarget: scholar.google.com/citations?user=REO9YogAAAAJ&hl=en